| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | myo-inositol | 7452 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 8822 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | myo-inositol | 9246 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 9827 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | myo-inositol | 12444 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | myo-inositol | 12821 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | myo-inositol | 17115 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 18099 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 18169 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | myo-inositol | 19756 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 22220 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 22598 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | myo-inositol | 23586 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 26080 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 27517 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
| GC POSITIVE ION MODE | myo-inositol | 30699 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 31949 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 32188 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 33013 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 33176 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
| GC POSITIVE ION MODE | myo-inositol | 33275 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 33631 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 34209 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | myo-inositol | 34845 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 35643 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 35884 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 35964 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 36334 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 37296 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 37397 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 37890 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | myo-inositol | 38861 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 40387 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | myo-inositol | 40523 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 40667 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 40890 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | myo-inositol | 42629 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | myo-inositol | 43351 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | myo-inositol | 46365 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | myo-inositol | 47089 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 49903 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | myo-inositol | 51494 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 56980 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | myo-inositol | 58223 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 58929 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | myo-inositol | 60218 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 60450 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | myo-inositol | 65360 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 68568 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 73425 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | myo-inositol | 74102 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | myo-inositol | 75273 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
| GC POSITIVE ION MODE | myo-inositol | 78663 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
| GC POSITIVE ION MODE | myo-inositol | 83590 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
| GC POSITIVE ION MODE | myo-inositol | 83699 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | myo-inositol | 92618 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | myo-inositol | 92841 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | myo-inositol | 95278 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|